INVESTMENT COUNSEL CO OF NEVADA is an institution, managing $49.1M across 77 long positions as of Q3 2025 with 67% ETF concentration, 78% concentrated in top 10 holdings, and 33% allocation to VOO.
Largest long holdings in INVESTMENT COUNSEL CO OF NEVADA's portfolio (78.2% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
ETF ETF | $16.5M | 33.49% | +$45.3K Bought | — 26.9K shares | |
Drug Manufacturers - General Healthcare | $4.9M | 10.00% | — | 0.00% 26.5K shares | |
ETF ETF | $4.9M | 9.90% | +$60.1K Bought | — 102.3K shares | |
ETF ETF | $2.5M | 5.12% | +$147.8K Bought | — 52.4K shares | |
ETF ETF | $2.0M | 4.16% | -$35.1K Sold | — 34.0K shares | |
Consumer Electronics Technology | $1.7M | 3.47% | -$1.1M Sold | 0.00% 6.7K shares | |
ETF ETF | $1.6M | 3.29% | +$192.8K Bought | — 2.4K shares | |
ETF ETF | $1.6M | 3.24% | +$4.6K Bought | — 5.2K shares | |
Aerospace & Defense Industrials | $1.5M | 3.09% | — | 0.00% 5.1K shares | |
Biotechnology Healthcare | $1.2M | 2.42% | — | 0.16% 85.0K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in INVESTMENT COUNSEL CO OF NEVADA's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
New | |
New |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
Sold |
Portfolio insights and performance metrics for INVESTMENT COUNSEL CO OF NEVADA
We use cookies for analytics. See our Privacy and Cookie Policy.